Blog

 
Shereese Maynard Shereese Maynard

The Mid-Year APP Plus Validation Framework

Many MSSP ACOs still have hidden denominator leakage, and with APP Plus’ all‑patient, all‑payer requirements, a rigorous mid‑year denominator review is now essential to protect both shared savings and compliance.

Read More
Shereese Maynard Shereese Maynard

Your ASM Score Is Being Built Right Now And You Can’t See It Yet

Most cardiology practices assume performance problems begin when dashboards turn yellow. They don't. By then, the operational damage is already months old. A missed follow-up, an incomplete medication reconciliation, or a silent denominator shift quietly erodes future MIPS and APP Plus scores long before submission season arrives. Green dashboards create false confidence while workflow instability accumulates underneath. The organizations winning under modern CMS models aren't just documenting care—they're defending continuity monthly. Because your future reimbursement isn't built during reporting season. It's being shaped right now, inside your daily workflows.

Read More
Shereese Maynard Shereese Maynard

Assigned, But Not Accounted For: Why Cardiac Attribution Errors Surface Too Late

Attribution errors rarely create immediate disruption. They build slowly, often unnoticed, embedded in workflows and data assumptions that appear stable on the surface. By the time these errors are visible, they are no longer easy to correct. They have already influenced performance scores, reporting accuracy, and financial outcomes. The absence of early signals is what makes them dangerous. If you are not actively managing attribution, you are reacting to it.

Read More
Shereese Maynard Shereese Maynard

Follow This Closely: Why Follow-Up Is the Weakest Link in Cardiac Care Measures

From a CMS perspective, incomplete follow-up is indistinguishable from incomplete care. Follow-up failures create gaps in the narrative of care. If a measure indicates successful management of a cardiac condition, there must be documented follow-up to support that claim. The practices that succeed in MIPS are not necessarily doing more, they are doing what they already do with greater precision, structure, and accountability. Because in cardiac measures, the weakest link is not diagnosis or treatment. It is whether you can prove that the care continued.

Read More
Shereese Maynard Shereese Maynard

Where Virtual Cardiac Care Loses Reportable Value

If your virtual cardiac care program is not mapped to reporting logic, then you are not just missing points, you are leaving defensible revenue on the table. From a CMS perspective, if the data is not captured in the right place, at the right time, and in the right format, it does not exist. The difference between high-performing programs and underperforming ones is no longer the care itself. It is whether that care can be measured, reported, and defended.

Read More
Shereese Maynard Shereese Maynard

CMS Is Expanding Audits Nationwide: How MIPS Providers Can Prove Their Data Holds Up in 2026

In 2026, CMS is expanding audits beyond Medicaid into MIPS. Audit defensibility, proving every reported number with clinical documentation, now matters more than on-time submission. Most failures stem from missing documentation or misaligned EHR data. The question is no longer whether you submitted. It is whether you can stand behind every number you reported.

Read More
Shereese Maynard Shereese Maynard

From No-Shows to Closed Loops: Using Automated Text Reminders to Improve Cardiac Screening Rates and MIPS Performance

The difference between no-shows and closed loops is not subtle. It is measurable in your data, visible in your workflows, and reflected in your reimbursement. If your current system cannot consistently move patients from identification to completed screening within the reporting period, the issue is not patient behavior; it is workflow design.

Read More
Shereese Maynard Shereese Maynard

If You Can’t Explain the Data, You Can’t Defend It

In today’s CMS validation environment, having the right number is no longer enough; the organization must also be able to explain exactly how that number was produced. Traceability has become the new standard, meaning data must be connected back to its source in the patient record and through every step of reporting. When that path is unclear, even accurate data can be difficult to defend under audit.

Read More
Shereese Maynard Shereese Maynard

Risk Exposure Snapshot: Where Most Practices Are Vulnerable Right Now

Most practices assume compliance is handled. Data submitted. Measures selected. Attestations complete. But in 2026, CMS isn't just evaluating what you submitted — they're evaluating whether your process holds up under scrutiny. And that gap is exactly where most organizations are exposed.

Read More
Shereese Maynard Shereese Maynard

AI in Compliance Workflows: Risk vs Efficiency

AI boosts compliance efficiency for ACOs/MIPS but demands governance, without human validation and traceability, it risks audit failures, Shared Savings losses, and CMS recoupments in 2026.

Read More
Shereese Maynard Shereese Maynard

Why March Determines 2026 Shared Savings

Most ACO leaders assume Shared Savings are won or lost in December, but by then, the outcome is already set. March quietly defines your 2026 performance year. Attribution is stabilizing, quality workflows are taking shape, and documentation habits are hardening.

Read More
Shereese Maynard Shereese Maynard

Why ACO Governance Matters More Than Benchmarks

While ACOs chase endless benchmarks - quality scores, cost metrics, MIPS performance - high performers know the real driver of success isn't tighter targets, but stronger governance that turns data into decisions and alignment.

Read More